NGL Fine-Chem Limited (BOM:524774)

India · Delayed Price · Currency is INR

2,404.35

+72.40 (3.10%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	3.68B	3.39B	2.78B	3.18B	2.58B
Pharmaceuticals Growth	8.73%	21.79%	-12.42%	23.08%	70.07%
Total	3.68B	3.39B	2.78B	3.18B	2.58B
Total Growth	8.73%	21.79%	-12.42%	23.08%	70.07%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	938.73M	792.74M	603.03M	748.58M	572.53M
India Growth	18.42%	31.46%	-19.44%	30.75%	49.43%
Europe	439.36M	704.59M	808.38M	871.59M	806.81M
Europe Growth	-37.64%	-12.84%	-7.25%	8.03%	62.37%
Asia Pacific	1.13B	980.01M	927.40M	937.69M	820.57M
Asia Pacific Growth	15.15%	5.67%	-1.10%	14.27%	90.61%
USA	47.88M	62.03M	55.08M	98.40M	68.13M
USA Growth	-22.82%	12.62%	-44.02%	44.43%	2919.55%
Rest of The World	1.08B	797.74M	341.86M	472.01M	281.96M
Rest of The World Growth	34.85%	133.36%	-27.58%	67.40%	59.53%
Total	3.63B	3.34B	2.74B	3.13B	2.55B
Total Growth	8.79%	21.98%	-12.55%	22.68%	71.19%

Source: S&P Global Market Intelligence.